{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:14:04Z","timestamp":1777878844650,"version":"3.51.4"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["IT1448\\u201322"],"award-info":[{"award-number":["IT1448\\u201322"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["PRE2022\\u2013102058"],"award-info":[{"award-number":["PRE2022\\u2013102058"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["PRE_2024_2_0058"],"award-info":[{"award-number":["PRE_2024_2_0058"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejps.2026.107466","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:05:54Z","timestamp":1770739554000},"page":"107466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mesenchymal stromal cell-free therapies for the treatment of inflammatory bowel disease"],"prefix":"10.1016","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6263-5848","authenticated-orcid":false,"given":"Camino","family":"Garcia-Blasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7063-7053","authenticated-orcid":false,"given":"Maria","family":"Rossello-Gelabert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6439-4569","authenticated-orcid":false,"given":"Manoli","family":"Igartua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7064-4563","authenticated-orcid":false,"given":"Edorta","family":"Santos-Vizcaino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3947-409X","authenticated-orcid":false,"given":"Rosa Maria","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejps.2026.107466_bib0001","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/j.cgh.2021.03.034","article-title":"Dual biologic or small molecule therapy for treatment of inflammatory bowel disease: a systematic review and meta-analysis","volume":"20","author":"Ahmed","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejps.2026.107466_bib0002","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1038\/s41598-020-58909-4","article-title":"TNF-\u03b1 and inf\u03b3 primed canine stem cell-derived extracellular vesicles alleviate experimental murine colitis","volume":"10","author":"An","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107466_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","article-title":"Interleukin-1 receptor antagonist: role in biology","volume":"16","author":"Arend","year":"1998","journal-title":"Annu. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.ejps.2026.107466_bib0005","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/MIB.0000000000000115","article-title":"Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis","volume":"20","author":"Armuzzi","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejps.2026.107466_bib0006","article-title":"Inflammatory and microbiota-related regulation of the intestinal epithelial barrier","volume":"8","author":"Barbara","year":"2021","journal-title":"Front. Nutr."},{"issue":"14","key":"10.1016\/j.ejps.2026.107466_bib0007","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJMra1907607","article-title":"Newer biologic and small-molecule therapies for inflammatory bowel disease","volume":"385","author":"Baumgart","year":"2021","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ejps.2026.107466_bib0009","series-title":"Protocolos Diagn\u00f3stico-Terap\u00e9uticos De Gastroenterolog\u00eda, Hepatolog\u00eda y Nutrici\u00f3n Pedi\u00e1trica","article-title":"Enfermedad inflamatoria intestinal","author":"Ben\u00edtez","year":"2010"},{"issue":"1","key":"10.1016\/j.ejps.2026.107466_bib0008","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.autrev.2013.06.002","article-title":"Optimizing anti-TNF treatments in inflammatory bowel disease","volume":"13","author":"Ben-Horin","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejps.2026.107466_bib0010","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1600-0854.2011.01225.x","article-title":"Exosome secretion: molecular mechanisms and roles in immune responses","volume":"12","author":"Bobrie","year":"2011","journal-title":"Traffic"},{"issue":"5","key":"10.1016\/j.ejps.2026.107466_bib0012","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S2468-1253(23)00003-1","article-title":"The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission","volume":"8","author":"Burisch","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.ejps.2026.107466_bib0011","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.cgh.2024.06.049","article-title":"The cost of inflammatory bowel disease care: how to make it sustainable","volume":"23","author":"Burisch","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejps.2026.107466_bib0013","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.maturitas.2018.01.015","article-title":"Clinical manifestations, pathophysiology, treatment and outcome of inflammatory bowel diseases in older people","volume":"110","author":"Butter","year":"2018","journal-title":"Maturitas"},{"issue":"9","key":"10.1016\/j.ejps.2026.107466_bib0014","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ki.2010.278","article-title":"Exosomes\/microvesicles as a mechanism of cell-to-cell communication","volume":"78","author":"Camussi","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejps.2026.107466_bib0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.intimp.2019.04.020","article-title":"Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization","volume":"72","author":"Cao","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.ejps.2026.107466_bib0016","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/cells8070764","article-title":"Mesenchymal stem cells for perianal Crohn\u2019s disease","volume":"8","author":"Carvello","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ejps.2026.107466_bib0017","doi-asserted-by":"crossref","first-page":"935","DOI":"10.33594\/000000065","article-title":"Human adipose-derived stem cells exhibit enhanced liver regeneration in acute liver injury by controlled releasing hepatocyte growth factor","volume":"52","author":"Choi","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"issue":"10014","key":"10.1016\/j.ejps.2026.107466_bib0018","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","article-title":"Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study","volume":"387","author":"Cleynen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2026.107466_bib0019","doi-asserted-by":"crossref","unstructured":"Coward, S., Benchimol, E.I., Bernstein, C.N., Avina-Zubieta, A., Bitton, A., Carroll, M.W., et al., 2024. Forecasting the incidence and prevalence of inflammatory bowel disease: a Canadian nationwide analysis. Am. J. Gastroenterol., 119(8), 1563\u20131570.","DOI":"10.14309\/ajg.0000000000002687"},{"issue":"4","key":"10.1016\/j.ejps.2026.107466_bib0020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10529-016-2272-3","article-title":"Antioxidant properties of mesenchymal stem cells against oxidative stress in a murine model of colitis","volume":"39","author":"Da Costa Gon\u00e7alves","year":"2017","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.ejps.2026.107466_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591065","article-title":"Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles: therapeutic outlook for inflammatory and degenerative diseases","volume":"11","author":"Dabrowska","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107466_bib0022","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jconrel.2023.01.017","article-title":"Oral delivery of layer-by-layer coated exosomes for colitis therapy","volume":"354","author":"Deng","year":"2023","journal-title":"J. Controlled Release"},{"issue":"10","key":"10.1016\/j.ejps.2026.107466_bib0023","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1167\/iovs.17-21506","article-title":"Mesenchymal stem cells promote diabetic corneal epithelial wound healing through TSG-6\u2013dependent stem cell activation and macrophage switch","volume":"58","author":"Di","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2026.107466_bib0024","first-page":"1551","article-title":"Extracellular vesicles derived from human placental mesenchymal stem cells alleviate experimental colitis in mice by inhibiting inflammation and oxidative stress","volume":"46","author":"Duan","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"6279","key":"10.1016\/j.ejps.2026.107466_bib0025","first-page":"1333","article-title":"Prostaglandin E\u2082 constrains systemic inflammation through an innate lymphoid cell\u2013IL-22 axis","volume":"351","author":"Duffin","year":"2016","journal-title":"Science (1979)"},{"issue":"23","key":"10.1016\/j.ejps.2026.107466_bib0026","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.3390\/cells11233738","article-title":"Interferon-gamma primed human clonal mesenchymal stromal cell sheets exhibit enhanced immunosuppressive function","volume":"11","author":"Dunn","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2026.107466_bib0027","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1305677","article-title":"Characterisation of adipocyte-derived extracellular vesicle subtypes identifies distinct protein and lipid signatures for large and small extracellular vesicles","volume":"6","author":"Durcin","year":"2017","journal-title":"J. ExtraCell Vesicles"},{"issue":"18","key":"10.1016\/j.ejps.2026.107466_bib0028","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.3390\/ijms20184597","article-title":"Insights into the secretome of mesenchymal stem cells and its potential applications","volume":"20","author":"Eleuteri","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2026.107466_bib0029","first-page":"27","article-title":"Morphology of inflammatory bowel diseases (Morfologie z\u00e1n\u011btliv\u00fdch st\u0159evn\u00edch onemocn\u011bn\u00ed)","volume":"58","author":"Fabi\u00e1n","year":"2022","journal-title":"Cesk. Patol."},{"key":"10.1016\/j.ejps.2026.107466_bib0030","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3389\/fimmu.2018.02837","article-title":"Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning","volume":"9","author":"Ferreira","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ejps.2026.107466_bib0032","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.ejps.2026.107466_bib0031","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1053\/j.gastro.2021.04.022","article-title":"AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn\u2019s disease","volume":"160","author":"Feuerstein","year":"2021","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.ejps.2026.107466_bib0033","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1097\/MIB.0000000000000138","article-title":"Antibodies against infliximab are associated with de novo development of antibodies to adalimumab and therapeutic failure in infliximab-to-adalimumab switchers with IBD","volume":"20","author":"Frederiksen","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejps.2026.107466_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201105","article-title":"Mesenchymal stem cell exosomes encapsulated oral microcapsules for acute colitis treatment","volume":"11","author":"Gan","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.ejps.2026.107466_bib0035","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3390\/curroncol29040223","article-title":"The economic burden of cancer in Canada from a societal perspective","volume":"29","author":"Garaszczuk","year":"2022","journal-title":"Curr. Oncol."},{"issue":"12","key":"10.1016\/j.ejps.2026.107466_bib0036","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/ecco-jcc\/jjab099","article-title":"Upadacitinib treatment improves symptoms of bowel urgency and abdominal pain and correlates with quality of life improvements in patients with moderate to severe ulcerative colitis","volume":"15","author":"Ghosh","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"issue":"19","key":"10.1016\/j.ejps.2026.107466_bib0037","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1182\/blood-2010-02-270777","article-title":"Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells","volume":"116","author":"Gieseke","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ejps.2026.107466_bib0038","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jcyt.2021.01.001","article-title":"Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell\u2013derived small extracellular vesicles","volume":"23","author":"Gimona","year":"2021","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.ejps.2026.107466_bib0039","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/17425247.2020.1714587","article-title":"Mesenchymal stromal cell-based therapies for the treatment of immune disorders: recent milestones and future challenges","volume":"17","author":"Gonzalez-Pujana","year":"2020","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2026.107466_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120266","article-title":"Multifunctional biomimetic hydrogel systems to boost the immunomodulatory potential of mesenchymal stromal cells","volume":"257","author":"Gonzalez-Pujana","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2026.107466_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120633","article-title":"Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs)","volume":"269","author":"Gorgun","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2026.107466_bib0042","article-title":"Exosomal MicroRNA-181a derived from mesenchymal stem cells improves gut microbiota composition, barrier function, and inflammatory status in an experimental colitis model","volume":"8","author":"Gu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"issue":"7","key":"10.1016\/j.ejps.2026.107466_bib0043","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management","volume":"11","author":"Harbord","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"10.1016\/j.ejps.2026.107466_bib0044","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1365-2036.2011.04619.x","article-title":"Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis","volume":"33","author":"Harris","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107466_bib0045","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1002\/jcp.26765","article-title":"The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells-conditioned medium in chronic colitis","volume":"233","author":"Heidari","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.ejps.2026.107466_bib0046","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41573-024-00953-0","article-title":"Peyrin-Biroulet L. Navigating the complexities of drug development for inflammatory bowel disease","volume":"23","author":"Honap","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.ejps.2026.107466_bib0047","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3349\/ymj.2017.58.5.1031","article-title":"Immune tolerance of human dental pulp\u2013derived mesenchymal stem cells mediated by CD4\u207aCD25\u207aFoxP3\u207a regulatory T-cells and induced by TGF-\u03b21 and IL-10","volume":"58","author":"Hong","year":"2017","journal-title":"Yonsei Med. J."},{"issue":"8067","key":"10.1016\/j.ejps.2026.107466_bib0048","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-025-08940-0","article-title":"Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group. Global evolution of inflammatory bowel disease across epidemiologic stages","volume":"642","author":"Hracs","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2026.107466_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108698","article-title":"Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells","volume":"107","author":"Huldani","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.ejps.2026.107466_bib0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41579-025-01163-0","article-title":"Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities","volume":"23","author":"Iliev","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"issue":"9","key":"10.1016\/j.ejps.2026.107466_bib0051","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.208884","article-title":"Galectins at a glance","volume":"131","author":"Johannes","year":"2018","journal-title":"J. Cell. Sci."},{"issue":"5","key":"10.1016\/j.ejps.2026.107466_bib0052","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1053\/j.gastro.2024.11.004","article-title":"Prevalence of pediatric inflammatory bowel disease in the United States: pooled estimates from three administrative claims data sources","volume":"168","author":"Kappelman","year":"2025","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ejps.2026.107466_bib0053","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/pr200682z","article-title":"Proteomic analysis of microvesicles derived from human mesenchymal stem cells","volume":"11","author":"Kim","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejps.2026.107466_bib0054","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4240\/wjgs.v16.i3.882","article-title":"Etanercept-synthesizing adipose-derived stem cell secretome: a promising therapeutic option for inflammatory bowel disease","volume":"16","author":"Kim","year":"2024","journal-title":"World J. Gastrointest. Surg."},{"issue":"4","key":"10.1016\/j.ejps.2026.107466_bib0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2468-1253(19)30013-5","article-title":"Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development","volume":"4","author":"King","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejps.2026.107466_bib0056","series-title":"Textbook of Pediatric Gastroenterology, Hepatology and Nutrition","article-title":"Inflammatory bowel disease unclassified (IBD-U)\/indeterminate colitis","author":"Kirschner","year":"2022"},{"key":"10.1016\/j.ejps.2026.107466_bib0057","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejps.2005.11.001","article-title":"Modulation of the rheological and mucoadhesive properties of thermosensitive poloxamer-based hydrogels intended for the rectal administration of quinine","volume":"27","author":"Koffi","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejps.2026.107466_bib0058","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2014.41","article-title":"MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease","volume":"28","author":"Kordelas","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ejps.2026.107466_bib0059","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: american College of Gastroenterology, Practice Parameters Committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am. J. Gastroenterol."},{"issue":"Supplement_2","key":"10.1016\/j.ejps.2026.107466_bib0060","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/jcag\/gwad008","article-title":"The 2023 impact of inflammatory bowel disease in Canada: direct health system and medication costs","volume":"6","author":"Kuenzig","year":"2023","journal-title":"J. Can. Assoc. Gastroenterol."},{"issue":"Supplement_2","key":"10.1016\/j.ejps.2026.107466_bib0061","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/jcag\/gwad009","article-title":"The 2023 impact of inflammatory bowel disease in Canada: indirect (individual and societal) and direct out-of-pocket costs","volume":"6","author":"Kuenzig","year":"2023","journal-title":"J. Can. Assoc. Gastroenterol."},{"issue":"9","key":"10.1016\/j.ejps.2026.107466_bib0062","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/scd.2016.0349","article-title":"Effect of the microenvironment on mesenchymal stem cell paracrine signaling: opportunities to engineer the therapeutic effect","volume":"26","author":"Kusuma","year":"2017","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.ejps.2026.107466_bib0063","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2217\/rme.11.35","article-title":"Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease","volume":"6","author":"Lai","year":"2011","journal-title":"Regen. Med."},{"issue":"7","key":"10.1016\/j.ejps.2026.107466_bib0064","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/nu11071532","article-title":"A personalised dietary approach\u2014A way forward to manage nutrient deficiency, effects of the western diet, and food intolerances in inflammatory bowel disease","volume":"11","author":"Laing","year":"2019","journal-title":"Nutrients"},{"issue":"Suppl 3","key":"10.1016\/j.ejps.2026.107466_bib0065","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.ejps.2026.107466_bib0066","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202000017","article-title":"Immune escape mediated by exosomal PD-L1 in cancer","volume":"4","author":"Lawler","year":"2020","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.ejps.2026.107466_bib0067","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.3748\/wjg.v27.i23.3342","article-title":"Conditioned secretome of adipose-derived stem cells improves dextran sulfate sodium-induced colitis in mice","volume":"27","author":"Lee","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejps.2026.107466_bib0068","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s12015-016-9677-1","article-title":"Therapeutic potential of secreted molecules derived from human amniotic fluid mesenchymal stem\/stroma cells in a mice model of colitis","volume":"12","author":"Legaki","year":"2016","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.ejps.2026.107466_bib0069","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00018-017-2473-5","article-title":"Interactions between mesenchymal stem cells and the immune system","volume":"74","author":"Li","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"26","key":"10.1016\/j.ejps.2026.107466_bib0070","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2026.107466_bib0071","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.29509","article-title":"High-speed centrifugation induces aggregation of extracellular vesicles","volume":"4","author":"Linares","year":"2015","journal-title":"J. ExtraCell Vesicles"},{"key":"10.1016\/j.ejps.2026.107466_bib0072","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131273","article-title":"Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight."},{"key":"10.1016\/j.ejps.2026.107466_bib0074","article-title":"Conditioned medium of mesenchymal stem cells pretreated with H2O2 promotes intestinal mucosal repair in acute experimental colitis","volume":"12","author":"Liu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107466_bib0073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.07.001","article-title":"Recent advances in the treatment of IBD: targets, mechanisms and related therapies","volume":"71-72","author":"Liu","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejps.2026.107466_bib0075","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.27031","article-title":"Optimized exosome isolation protocol for cell culture supernatant and human plasma","volume":"4","author":"Lobb","year":"2015","journal-title":"J. ExtraCell Vesicles"},{"issue":"5","key":"10.1016\/j.ejps.2026.107466_bib0076","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/medicina58050567","article-title":"Inflammatory bowel disease: clinical diagnosis and surgical treatment\u2014Overview","volume":"58","author":"M\u2019Koma","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ejps.2026.107466_bib0077","series-title":"StatPearls","article-title":"Extraintestinal manifestations of inflammatory bowel disease","author":"Malik","year":"2023"},{"issue":"23","key":"10.1016\/j.ejps.2026.107466_bib0078","doi-asserted-by":"crossref","first-page":"38008","DOI":"10.18632\/oncotarget.16682","article-title":"Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease","volume":"8","author":"Mao","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.ejps.2026.107466_bib0079","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5356760","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice","volume":"2017","author":"Mao","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.ejps.2026.107466_bib0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13287-022-03054-0","article-title":"Clinical application of mesenchymal stem cells in regenerative medicine: a narrative review","volume":"13","author":"Margiana","year":"2022","journal-title":"Stem Cell Res. Ther."},{"issue":"4","key":"10.1016\/j.ejps.2026.107466_bib0081","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/1744666X.2023.2174971","article-title":"The oft-overlooked cardiovascular complications of inflammatory bowel disease","volume":"19","author":"Massironi","year":"2023","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.ejps.2026.107466_bib0082","first-page":"940","article-title":"Therapeutic effects of human amnion-derived mesenchymal stem cell transplantation and conditioned medium enema in rats with trinitrobenzene sulfonic acid-induced colitis","volume":"9","author":"Miyamoto","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"6","key":"10.1016\/j.ejps.2026.107466_bib0083","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3390\/nu11061239","article-title":"Towards a food pharmacy: immunologic modulation through diet","volume":"11","author":"Molendijk","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ejps.2026.107466_bib0084","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00018-019-03071-y","article-title":"Extracellular vesicle isolation methods: rising impact of size-exclusion chromatography","volume":"76","author":"Monguio-Tortajada","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejps.2026.107466_bib0085","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.xphs.2017.02.030","article-title":"Pharmacokinetics of exosomes \u2013 an important factor for elucidating the biological roles of exosomes and for the development of exosome-based therapeutics","volume":"106","author":"Morishita","year":"2017","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2026.107466_bib0086","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cellimm.2008.06.002","article-title":"Leukemia inhibitory factor: role in human mesenchymal stem cells\u2013mediated immunosuppression","volume":"253","author":"Nasef","year":"2008","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ejps.2026.107466_bib0087","article-title":"Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in IBD patients: clinical trial phase I","volume":"10","author":"Nazari","year":"2022","journal-title":"Gastroenterol. Rep. (Oxf)"},{"key":"10.1016\/j.ejps.2026.107466_bib0088","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/14712598.2021.1825677","article-title":"Small extracellular vesicles (sEVs): discovery, functions, applications, detection methods and various engineered forms","volume":"21","author":"Negahdaripour","year":"2021","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"5","key":"10.1016\/j.ejps.2026.107466_bib0089","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrgastro.2016.208","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.ejps.2026.107466_bib0090","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1056\/NEJMct1209614","article-title":"Tumor necrosis factor inhibitors for inflammatory bowel disease","volume":"369","author":"Nielsen","year":"2013","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ejps.2026.107466_bib0091","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9415367","article-title":"Bioprocessing of mesenchymal stem cells and their derivatives: toward cell-free therapeutics","volume":"2018","author":"Phelps","year":"2018","journal-title":"Stem Cells Int."},{"issue":"7","key":"10.1016\/j.ejps.2026.107466_bib0092","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.tibtech.2023.01.003","article-title":"Manufacture of extracellular vesicles derived from mesenchymal stromal cells","volume":"41","author":"Pincela Lins","year":"2023","journal-title":"Trends Biotechnol."},{"issue":"14","key":"10.1016\/j.ejps.2026.107466_bib0093","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1089\/scd.2016.0048","article-title":"Unveiling the differences of secretome of human bone marrow mesenchymal stem cells, adipose tissue-derived stem cells, and human umbilical cord perivascular cells: a proteomic analysis","volume":"25","author":"Pires","year":"2016","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.ejps.2026.107466_bib0094","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.intimp.2017.11.001","article-title":"Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis","volume":"54","author":"Pouya","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"Suppl 2","key":"10.1016\/j.ejps.2026.107466_bib0095","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/ibd\/izae082","article-title":"Challenges in IBD Research 2024: novel Technologies","volume":"30","author":"Prasad","year":"2024","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.ejps.2026.107466_bib0097","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2022.07.002","article-title":"Clinical progress in MSC-based therapies for the management of severe COVID-19","volume":"68","author":"Rossello-Gelabert","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.ejps.2026.107466_bib0098","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13287-025-04315-4","article-title":"Fine-tuning licensing strategies to boost MSC-based immunomodulatory secretome","volume":"16","author":"Rossello-Gelabert","year":"2025","journal-title":"Stem Cell Res. Ther."},{"issue":"25","key":"10.1016\/j.ejps.2026.107466_bib0096","first-page":"00501","article-title":"Translational pathways for MSC secretome therapies: from bioprocessing to delivery","volume":"S0167-7799","author":"Rossello-Gelabert","year":"2026","journal-title":"Trends in biotechnology,"},{"key":"10.1016\/j.ejps.2026.107466_bib0099","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.3390\/cells9091955","article-title":"Methods for separation and characterization of extracellular vesicles: results of a worldwide survey performed by the ISEV rigor and standardization subcommittee","volume":"9","author":"Royo","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.ejps.2026.107466_bib0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ejps.2026.107466_bib0101","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/ijms24021526","article-title":"Pathophysiology of inflammatory bowel disease: innate immune system","volume":"24","author":"Saez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107466_bib0003","unstructured":"Safety of injection of placental mesenchymal stem cell derived exosomes for treatment of resistant perianal fistula in Crohn\u00b4s disease patients. Bethesda: U.S. National Library of Medicine, 2022 [updated August 12, 2022]. Accessed July 02, 2025, at https:\/\/clinicaltrials.gov\/study\/NCT05499156."},{"issue":"9 Suppl","key":"10.1016\/j.ejps.2026.107466_bib0102","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/TP.0b013e3181a2a4b3","article-title":"HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells","volume":"87","author":"Selmani","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ejps.2026.107466_bib0103","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3390\/pharmaceutics13081127","article-title":"Tailored hydrogels as delivery platforms for conditioned medium from mesenchymal stem cells in a model of acute colitis in mice","volume":"13","author":"Sendon-Lago","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107466_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110076","article-title":"Mesenchymal stromal cell-derived membrane particles: a novel cell-free therapy for inflammatory bowel diseases","volume":"118","author":"Serafini","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.ejps.2026.107466_bib0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian","year":"2019","journal-title":"J. Med. Life"},{"issue":"1","key":"10.1016\/j.ejps.2026.107466_bib0106","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41392-024-01936-8","article-title":"Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges","volume":"9","author":"Shan","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ejps.2026.107466_bib0107","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.reth.2025.04.005","article-title":"Method standardization of secretome production, collection, and characterization: new insights and challenges","volume":"29","author":"Singh","year":"2025","journal-title":"Regen. Ther."},{"issue":"6","key":"10.1016\/j.ejps.2026.107466_bib0108","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41575-025-01063-x","article-title":"Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response","volume":"22","author":"Solitano","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejps.2026.107466_bib0109","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1038\/s41598-017-09827-5","article-title":"Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages","volume":"7","author":"Song","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ejps.2026.107466_bib0110","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/sctm.17-0305","article-title":"Mesenchymal stem cells (MSC) derived from induced pluripotent stem cells (iPSC) are equivalent to adipose-derived MSC in promoting intestinal healing and microbiome normalization in a mouse inflammatory bowel disease model","volume":"7","author":"Soontararak","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ejps.2026.107466_bib0111","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/gels3030025","article-title":"Polymeric hydrogels as technology platform for drug delivery applications","volume":"3","author":"Sosnik","year":"2017","journal-title":"Gels"},{"key":"10.1016\/j.ejps.2026.107466_bib0112","unstructured":"Study of DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn\u00b4s Disease. Bethesda: U.S. National Library of Medicine, 2022 [updated June 15, 2025]. (Accessed July 02, 2025, at https:\/\/clinicaltrials.gov\/study\/NCT06918808)."},{"key":"10.1016\/j.ejps.2026.107466_bib0113","unstructured":"Study of ExoFlo For the Treatment of Medically Refractory Crohn\u2019s Disease. Bethesda: U.S. National Library of Medicine, 2023 [updated February 11, 2025]. (Accessed July 02, 2025, at https:\/\/clinicaltrials.gov\/study\/NCT05130983.)."},{"key":"10.1016\/j.ejps.2026.107466_bib0114","unstructured":"Study of ExoFlo For the Treatment of Medically Refractory Ulcerative Colitis. Bethesda: U.S. National Library of Medicine, 2022 [updated February 11, 2025]. (Accessed July 02, 2025, at https:\/\/clinicaltrials.gov\/study\/NCT05176366.)."},{"key":"10.1016\/j.ejps.2026.107466_bib0115","unstructured":"Study of ExoFlo For the TREatment of PERIANAL FISTUlas. Bethesda: U.S. National Library of Medicine, 2022 [updated February 11, 2025]. (Accessed July 02, 2025, at https:\/\/clinicaltrials.gov\/study\/NCT05836883)."},{"issue":"6","key":"10.1016\/j.ejps.2026.107466_bib0116","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/j.gastro.2013.10.047","article-title":"American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti\u2013TNF-\u03b1 biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease","volume":"145","author":"Terdiman","year":"2013","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ejps.2026.107466_bib0117","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1089\/scd.2012.0266","article-title":"Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells","volume":"22","author":"Tomasoni","year":"2013","journal-title":"Stem Cells Dev."},{"issue":"1","key":"10.1016\/j.ejps.2026.107466_bib0118","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in Crohn's disease: medical treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J. Crohn's Colitis"},{"key":"10.1016\/j.ejps.2026.107466_bib0119","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0140-6736(78)91816-0","article-title":"Further experience in the treatment of severe attacks of ulcerative colitis","volume":"2","author":"Truelove","year":"1978","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ejps.2026.107466_bib0120","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s10620-021-07200-1","article-title":"Systematic review and meta-analysis: risk of hospitalization in patients with ulcerative colitis and Crohn\u2019s disease in population-based cohort studies","volume":"67","author":"Tsai","year":"2022","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2026.107466_bib0121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-017-0045-6","article-title":"Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases","volume":"37","author":"Tsuchiya","year":"2017","journal-title":"Inflamm. Regen."},{"issue":"7","key":"10.1016\/j.ejps.2026.107466_bib0122","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/scd.2013.0335","article-title":"Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations","volume":"23","author":"Ungerer","year":"2014","journal-title":"Stem Cells Dev."},{"issue":"9","key":"10.1016\/j.ejps.2026.107466_bib0123","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/ijms18091852","article-title":"Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine","volume":"18","author":"Vizoso","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107466_bib0124","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00535-013-0901-3","article-title":"Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors","volume":"49","author":"Watanabe","year":"2014","journal-title":"J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ejps.2026.107466_bib0125","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. ExtraCell Vesicles"},{"issue":"18","key":"10.1016\/j.ejps.2026.107466_bib0126","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1021\/acs.chemrev.0c00895","article-title":"Immunomodulatory biomaterials for tissue repair","volume":"121","author":"Whitaker","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2026.107466_bib0127","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","volume":"4","author":"Wiklander","year":"2015","journal-title":"J. ExtraCell Vesicles"},{"issue":"492","key":"10.1016\/j.ejps.2026.107466_bib0128","doi-asserted-by":"crossref","first-page":"eaav8521","DOI":"10.1126\/scitranslmed.aav8521","article-title":"Advances in therapeutic applications of extracellular vesicles","volume":"11","author":"Wiklander","year":"2019","journal-title":"Sci. Translat. Medi."},{"key":"10.1016\/j.ejps.2026.107466_bib0129","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3389\/fimmu.2019.01091","article-title":"IL-33 and IL-18 in inflammatory bowel disease etiology and microbial interactions","volume":"10","author":"Williams","year":"2019","journal-title":"Front. Immunol."},{"issue":"Supplement_2","key":"10.1016\/j.ejps.2026.107466_bib0130","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/jcag\/gwad003","article-title":"The 2023 impact of inflammatory bowel disease in Canada: executive summary","volume":"6","author":"Windsor","year":"2023","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"10.1016\/j.ejps.2026.107466_bib0131","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1609206","article-title":"Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications","volume":"8","author":"Witwer","year":"2019","journal-title":"J. ExtraCell Vesicles"},{"key":"10.1016\/j.ejps.2026.107466_bib0133","first-page":"2026","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease in mice through ubiquitination","volume":"10","author":"Wu","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ejps.2026.107466_bib0132","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.intimp.2018.12.043","article-title":"Extracellular vesicles containing miR-146a attenuate experimental colitis by targeting TRAF6 and IRAK1","volume":"68","author":"Wu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejps.2026.107466_bib0134","article-title":"Extracellular vesicles derived from bone marrow mesenchymal stem cells protect against experimental colitis via attenuating colon inflammation, oxidative stress and apoptosis","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ejps.2026.107466_bib0135","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41419-020-02788-0","article-title":"IFN-\u03b3 promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejps.2026.107466_bib0136","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/acfadb","article-title":"Colon-targeted EMSCs conditional medium hydrogel for treatment of ulcerative colitis in mice","volume":"18","author":"Yang","year":"2023","journal-title":"Biomed. Mater."},{"issue":"5","key":"10.1016\/j.ejps.2026.107466_bib0137","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.stemcr.2018.09.012","article-title":"Connexin 43-mediated mitochondrial transfer of iPSC-MSCs alleviates asthma inflammation","volume":"11","author":"Yao","year":"2018","journal-title":"Stem Cell Rep."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:29:17Z","timestamp":1777591757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726000400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":137,"alternative-id":["S0928098726000400"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107466","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stromal cell-free therapies for the treatment of inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107466"}}